KAT2A and myelodysplastic syndrome: Comparison of RNA-seq from triple-mutant leukemias versus triple-mutant preleukemias, or versus Idh1R132H alone, revealed a gene signature that was specific to the leukemia state and in which down-regulated genes were enriched for KAT2A chromatin targets (fig.